Posted 14th January 2019 by Jane Williams
In the first part of this six-part blog series, we looked at the challenges facing the pathology department. The conversation then moved onto the key blockers standing in the way of the adoption of digital pathology.
If you weren’t able to make the panel discussion, you can watch the recording here.
Posted 11th January 2019 by Kieran Chambers
As the understanding of the role that bacterial ecosystems play within human and animal health deepens, so has the increase in the amount of research and companies focusing on the Microbiome. If you were unable to attend the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Edward Burd, Kathy McCoy & Jan Majta available.
Posted 9th January 2019 by Kieran Chambers
Bas Trietsch is the CTO and co-founder of MIMETAS and co-inventor of the OrganoPlate. As CTO he currently drives the continued product development of the OrganoPlate and its peripheral equipment.
Here, Bas talks about what the future holds for organ-on-a-chip and other breakthroughs technologies in biology.
Posted 7th January 2019 by Jane Williams
It was a pleasure to welcome key opinion leaders to a discussion on accelerating the impact of AI through 100% digitization of the pathology workflow. Chaired by Peter Hamilton, Head of Research at Philips Digital & Computational Pathology, barriers to adoption, what drives the need and how do we reap the benefits were all on the agenda.
If you weren’t able to make the panel discussion, this six-part blog series will uncover what was discussed. Alternatively, you can watch the recording here.
Posted 2nd January 2019 by Kieran Chambers
Whilst microbiome as a whole is gaining traction, developments in wound healing, skin ageing and inflammation have garnered a wider understanding of the skin microbiome in health and disease. If you were unable to attend the dedicated Skin Microbiome track at the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Madhuri Jasti, Mark Wilson and Kausar Malik available here.
Posted 28th December 2018 by Jane Williams
This article is republished with kind permission from Biovox. The original article can be found here.
Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a global effort, the TEDDY study, to understand what causes the disorder and pave the way for effective interventions. A number of analyses emerging from TEDDY are now bringing into focus the role of the microbiome in T1D. We now ask the question: could the microbiome be the key to intercepting and preventing T1D?